Anti-cancer activity elucidation of geissolosimine as an MDM2-p53 interaction inhibitor: An in-silico study.

MI-773 - Ascenta, Sanofi

http://www.ncbi.nlm.nih.gov/pubmed/40339040

Ayesha Siddika; Elmu Kabir Rafa; Jannatul Mawa Etee; Md Al-Amin; Md Faruk Hossen; Md Helal Uddin; Md Rasul Karim; Nafisa Akter; Ratul Mahmud; Rehnuma Tanjin; Samira Idris Mowlee; Sumi Akter; Tasfia Saffat

May 9, 2025